Selective Cytotoxic and Chemoprotective effect of Epigallocatechine-3-Gallate against human HCT-116 cell line | ||
Biochemistry Letters | ||
Article 15, Volume 15, Issue 1, 2019, Pages 196-205 | ||
Document Type: Original Article | ||
DOI: 10.21608/blj.2019.146624 | ||
Authors | ||
Youssef M. Shehata1; Nermin Raafat2; Mohammed A. Hussien3; Elsayed M. Elsayed4 | ||
11. Professor of Biochemistry, Faculty of Veterinary Medicine, Zagazig University. | ||
2Assistant Professor of Medical Biochemistry, Faculty of Medicine, Zagazig University. | ||
3Assistant Professor of Biochemistry, Faculty of Veterinary Medicine, Zagazig University. | ||
4B.V. SC , Faculty of Veterinary Medicine, Zagazig University | ||
Abstract | ||
Background: Epigallocatechin-3-gallate use as antioxidant and anticancer may related to its high bioavailability. Aim: this study was designed to investigate the possible chemoprotective and cytotoxic effect of Epigallocatechin-3-gallate against Human colorectal carcinoma (HCT-116) cell line. Material and methods: MTT assay was performed to detect the cytotoxic effect of Epigallocatechine-3-Gallate against normal and HCT-116 cells, and determination of gene expression of VEGF,BFGF and Caspase-3 was performed to detect the apoptotic effect of Epigallocatechin-3-gallate Results: Epigallocatechin-3-gallate has a selective cytotoxic effect on human HCT-116 cells with no cytotoxic effect on healthy cells. At the same time, Epigallocatechine-3-Gallate increases the expression of Caspase-3 with reduction in expression of BFGF, VEGF gene . Conclusion: Epigallocatechine-3-Gallate has selective cytotoxic and chemoprotective effect against human HCT-116 cells according to its dose used. | ||
Keywords | ||
Colorectal Cancer; HCT-116; Epigallocatechine-3-Gallate; MTTassay; BFGF; VEGF; Caspase-3 | ||
Statistics Article View: 301 |